Both CLEC4M and DC-SIGN have long been considered to perform the same function of recognizing a range of pathogens and mediating the endocytosis of ligands11, 12, but emerging evidence has demonstrated some differences between their roles in immunity and tumour progression. Here, CLEC4M is linked to neoplasm.